stockportfolio.pro
Stocks / BUD vs CL
BUD vs CL
Anheuser-Busch InBev SA/NV and Colgate-Palmolive Company side by side — fundamentals from SEC filings, refreshed nightly. Sector: Consumer Defensive.
| Anheuser-Busch InBev SA/NV (BUD) | Colgate-Palmolive Company (CL) | |
|---|---|---|
| Market cap | $159.2B | $72.5B |
| Revenue (latest FY) | $59.32B | $20.38B |
| Net income (latest FY) | $6.84B | $2.13B |
| Revenue growth (5y CAGR) | 0.9% | 4.4% |
| Net margin | 11.5% | 10.5% |
| Return on equity | 7.8% | 3948.1% |
| P/E ratio | 22.8 | 34.7 |
| Dividend yield | 1.7% | 2.4% |
| Profitable years (of last 10) | 4 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open BUD — free Open CL — freeFrequently asked questions
Which is bigger, BUD or CL?
Anheuser-Busch InBev SA/NV is larger by market capitalization — $159.2B versus $72.5B.
Which grows faster, BUD or CL?
Over the last five fiscal years, Colgate-Palmolive Company grew revenue faster — 4.4%/yr versus 0.9%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.